Suraksha Diagnostic moves up on planning to invest Rs 200 crore to set up over 20 centres across eastern India
Suraksha Diagnostic is currently trading at Rs. 324.90, up by 0.90 points or 0.28 % from its previous closing of Rs. 324.00 on the BSE.
The scrip opened at Rs. 325.00 and has touched a high and low of Rs. 325.60 and Rs. 320.65 respectively. So far 1548 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 449.00 on 06-Dec-2024 and a 52 week low of Rs. 233.15 on 04-Mar-2025.
Last one week high and low of the scrip stood at Rs. 331.40 and Rs. 317.85 respectively. The current market cap of the company is Rs. 1690.02 crore.
The promoters holding in the company stood at 48.78 % while Institutions and Non-Institutions held 36.51 % and 14.70 % respectively.
Suraksha Diagnostic is planning to invest Rs 200 crore to set up over 20 advanced imaging centres across eastern India. The plan, which will be executed in collaboration with United Imaging, is aimed at expanding access to advanced diagnostic services in tier 2 and tier 3 cities, enhancing both affordability and healthcare quality in smaller towns and semi-urban regions.
United Imaging will supply cutting-edge imaging solutions, while Suraksha Diagnostics will leverage its existing network and operational expertise to set up the new centres. Suraksha Diagnostics raised Rs 846.25 crore through an IPO in December for funding its expansion plans. At present, it operates 59 diagnostic centres and 166 sample collection centres across West Bengal, Bihar, Assam, and Meghalaya.
Suraksha Diagnostic is primarily engaged in the business of running diagnostic centres for carrying out various pathological and radiological services.
